ATTENTION ALL CUSTOMERS:
Due to a recent change of our website, the process for submitting refill requests online has now changed.
Please click on “Sign Up Today!” to create a new account, and be sure to download our NEW Mobile app!
Thank you for your patience during this transition
104 North Lincoln Boulevard, Hodgenville, KY 42748 | Phone: (270) 358-3306 | Fax: (270) 358-8080 | Mon-Fri 9:00am - 6:00pm | Sat 9:00am - 2:00pm | Sun Closed

Get Healthy!

  • Posted December 16, 2025

Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?

In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”

Health News is provided as a service to Smith Drug Company site users by HealthDay. Smith Drug Company nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.